grant

Core 3 - Immunobiology Core

Organization DUKE UNIVERSITYLocation DURHAM, UNITED STATESPosted 14 Jun 2022Deadline 31 Mar 2027
NIHUS FederalResearch GrantFY2026AIDS VirusAIDS/HIVAcquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAffinityAnatomic SitesAnatomic structuresAnatomyAnti-HIV PositivityAntibodiesAntibody AffinityAntigensAssayAutologousB blood cellsB cellB cell receptorB cellsB-Cell ActivationB-Cell Antigen ReceptorB-CellsB-LymphocytesB-cellBindingBioassayBiochemicalBiological AssayCell BodyCell Communication and SignalingCell IsolationCell LineCell SegregationCell SeparationCell Separation TechnologyCell SignalingCell surfaceCellLineCellsCellular AssayCellular ImmunologyClass II AntigensClass II Major Histocompatibility AntigensClosure by LigationCommunitiesCryofixationCryopreservationDNA cassetteDevelopmentDistalEducational process of instructingEducational workshopEnv trimerEvaluationEventEvolutionExperimental DesignsFlow CytofluorometriesFlow CytofluorometryFlow CytometryFlow MicrofluorimetryFlow MicrofluorometryGerminal CenterGoalsHIVHIV AntibodiesHIV EnvHIV PositiveHIV PositivityHIV SeroconversionHIV SeropositivityHIV antibody positiveHIV envelopeHIV envelope proteinHIV glycoprotein EnvHIV+HIV-1HIV-1 EnvHIV-1 envelopeHIV-1 glycoprotein EnvHIV-Associated AntibodiesHIV-IHIV/AIDSHIV1HTLV-III AntibodiesHTLV-III SeroconversionHTLV-III SeropositivityHTLV-III-LAV AntibodiesHelper CellsHelper T-CellsHelper T-LymphocytesHelper-Inducer T-CellsHelper-Inducer T-LymphocyteHistocompatibility Antigens Class IIHumanHuman Immunodeficiency Virus Type 1Human Immunodeficiency Virus-1Human Immunodeficiency VirusesHuman ResourcesHuman T-Lymphotropic Virus Type III AntibodiesHuman immunodeficiency virus 1I-A AntigenIa AntigensIa-Like AntigensImmune EvasionImmune Response AntigensImmune systemImmune-Response-Associated AntigensImmunoassayImmunobiologyImmunochemical ImmunologicImmunologicImmunologicalImmunologicallyImmunologicsImmunologyImmunophysiologyIn VitroIndividualInducer CellsInducer T-LymphocytesInfectionInstitutionIntracellular Communication and SignalingInvestigationInvestigatorsJournalsKI miceKnock-in MouseLAV AntibodiesLAV-HTLV-IIILaboratoriesLeadLeukapheresisLeukocytapheresisLigationLightLymphadenopathy-Associated AntibodiesLymphadenopathy-Associated VirusMHC Class II MoleculeMHC Class II ProteinMHC class II antigenMagazineMajor Histocompatibility Complex Class IIManpowerMeasurementMeasuresMembraneMethodologyMethodsMiceMice MammalsModern ManMolecular ImmunologyMolecular InteractionMurineMusPb elementPeptidesPersonsPhotoradiationPlasmidsProductionProteinsProtocolProtocols documentationR-Series Research ProjectsR01 MechanismR01 ProgramRT-PCRReagentReceptor SignalingRecoveryReproducibilityResearchResearch GrantsResearch PersonnelResearch Project GrantsResearch ProjectsResearch ResourcesResearchersResistanceResourcesReverse Transcriptase Polymerase Chain ReactionSamplingServicesSignal InductionSignal TransductionSignal Transduction SystemsSignalingSortingStrains Cell LinesStructureStructure of germinal center of lymph nodeT-Cell ActivationT-CellsT-LymphocyteTeachingTechniquesTechnologyTherapeutic LeukopheresisTransfectionTranslatingUniversitiesVaccinesViralViral reservoirVirus reservoirVirus-HIVWorkWorkshopactivate T cellsactivated B cellsantigen antibody affinityantiretroviral therapyantiretroviral treatmentbiological signal transductioncell assaycell sortingcold preservationcold storagecultured cell linedevelopmentalenhancer cassetteexpectationexperimental analysisexpression cassetteextracellular vesiclesflow cytophotometrygene cassettegene productgenetic cassetteheavy metal Pbheavy metal leadimmune evasiveimmunogenin vitro Assayinsightintegration cassetteinter-institutionalknockin micemembrane structureneutralizing antibodynew approachesnovelnovel approachesnovel strategiesnovel strategypersonnelpromoter cassettereporter cassetteresistance cassetteresistantreverse transcriptase PCRscreeningscreeningsselectable cassetteselection cassettestop cassettestructural biologysuccessthymus derived lymphocytetranscription cassettetranscriptional cassettetransgene cassetteuptakeviral reboundvirologyvirus rebound
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Abstract – Core 3 – Immunobiology Core Approximately 40 million people worldwide are living with HIV/AIDS; however, a protective vaccine or functional cure remain elusive despite four decades of intense research. HIV-1 evades the immune system through its rapid structural evolution during infection and replication. The Duke Center for HIV Structural Biology will pursue structural studies of the evolution of the HIV-1 Envelope (Env) protein to elucidate structure-function mechanisms for viral entry, B-cell and T-cell activation, and viral rebound after antiretroviral therapy ART. The Immunobiology Core (Core 3) brings together a team of investigators with extensive expertise in cellular and molecular immunology to provide comprehensive, centralized immunoassay services to support the efforts of the three projects and the other cores.

The overall objectives of the Immunobiology Core are to 1) support Projects 1, 2, and 3 with immunoassays and biochemical protocols to evaluate B cell receptor signaling in cell lines and knock- in mice, 2) provide assays for measurements of peptide presentation on MHCII as a read-out of B cell activation, and 3) support Project 3 by performing single B cell sorting from HIV-infected subjects for recovery and expression of Env-specific antibodies. The Immunobiology Core comprises facilities, technologies, and services housed in the cellular immunology laboratories of Dr. Cain (Core Lead) at the Duke Human Vaccine Institute (DHVI) and Dr. Borrow (Core Co-director) at Oxford University, the biomolecular interaction laboratory of Dr.

Alam (Core Co-director) at DVHI, the protein production laboratory of Dr. Saunders (DHVI), and the DHVI Flow Cytometry Facility. In addition to interactions with individual projects, the Immunobiology Core will also directly interface with the Developmental Core. Core personnel will work hand-in-hand with trainees at the bench for the teaching of assays, with emphasis on robust experimental design, proper technique, and appropriate analysis of experimental results.

As needed, the Core will host small-group workshops for trainees that focus on immunological topics or methodologies related to Core activities. The assays and services provided by the Immunobiology Core are critical to the success of the research projects. The provision of immunoassays will provide key insights into the propagation of signals induced by antigen-B cell receptor interactions at the B cell surface membrane, and the isolation of novel Env antibodies from HIV+ subjects will enable structural insights pertaining to suppression of the viral reservoir. Moreover, the methodologies and reagents developed in this Core will be made available to the research community for application in basic and applied structural immunology research.

Grant Number: 5U54AI170752-05
NIH Institute/Center: NIH

Principal Investigator: Derek Cain

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →